Laura & Isaac Perlmutter Cancer Center at NYU Langone Health — New York, New York

Public research footprint of Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Non-muscle Invasive Bladder Cancer · Ovarian Cancer · Melanoma

Recently updated registry entries

NCT07185997 — Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's… (Recruiting)
NCT06457503 — A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With… (Recruiting)
NCT05538130 — A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Laura & Isaac Perlmutter Cancer Center at NYU Langone Health?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.